Specific warning signs that tirzepatide should not be used include visible particles, cloudiness, or discoloration
This was the first major one raising concern, published in 2023
In actuarial terms, dedicating 12% of pre-tax income to a single drug is classified as a catastrophic medical expense, severely limiting long-term adherence
CVOT trial will help determine if tirzepatide can demonstrate superior cardiovascular safety and potential additional cardiovascular benefits compared to the currently approved GLP-1RA dulaglutide
My energy level is fine, nothing crazy, as I was afraid it would be with the B12
But if youre uninsured or want transparent cash pricing, Mochi falls short